IL158641A0 - Process for preparing a thiazole ppar-ligand and polymorphs thereof - Google Patents

Process for preparing a thiazole ppar-ligand and polymorphs thereof

Info

Publication number
IL158641A0
IL158641A0 IL15864102A IL15864102A IL158641A0 IL 158641 A0 IL158641 A0 IL 158641A0 IL 15864102 A IL15864102 A IL 15864102A IL 15864102 A IL15864102 A IL 15864102A IL 158641 A0 IL158641 A0 IL 158641A0
Authority
IL
Israel
Prior art keywords
polymorphs
preparing
ppar
thiazole
ligand
Prior art date
Application number
IL15864102A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL158641A0 publication Critical patent/IL158641A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
IL15864102A 2001-05-31 2002-05-29 Process for preparing a thiazole ppar-ligand and polymorphs thereof IL158641A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113232.3A GB0113232D0 (en) 2001-05-31 2001-05-31 Chemical process
PCT/EP2002/005884 WO2002096893A1 (en) 2001-05-31 2002-05-29 Process for preparing a thialzole ppar-ligand and polymorphs thereof

Publications (1)

Publication Number Publication Date
IL158641A0 true IL158641A0 (en) 2004-05-12

Family

ID=9915637

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15864102A IL158641A0 (en) 2001-05-31 2002-05-29 Process for preparing a thiazole ppar-ligand and polymorphs thereof

Country Status (22)

Country Link
US (1) US7244849B2 (xx)
EP (1) EP1395572B1 (xx)
JP (1) JP2004532265A (xx)
KR (1) KR20040007631A (xx)
CN (1) CN1551871A (xx)
AT (1) ATE315556T1 (xx)
AU (1) AU2002317764B2 (xx)
BR (1) BR0209892A (xx)
CA (1) CA2448101A1 (xx)
CO (1) CO5540298A2 (xx)
CZ (1) CZ20033256A3 (xx)
DE (1) DE60208682T2 (xx)
ES (1) ES2256493T3 (xx)
GB (1) GB0113232D0 (xx)
HU (1) HUP0400117A3 (xx)
IL (1) IL158641A0 (xx)
MX (1) MXPA03010943A (xx)
NO (1) NO20035313L (xx)
NZ (1) NZ529486A (xx)
PL (1) PL367114A1 (xx)
WO (1) WO2002096893A1 (xx)
ZA (1) ZA200308570B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105551B2 (en) * 2000-12-20 2006-09-12 Smithkline Beecham Corporation Thiazole derivatives for treating PPAR related disorders
CN1662487A (zh) 2002-06-19 2005-08-31 伊莱利利公司 酰胺连接基过氧化物酶体增殖物激活受体调节剂
TW200400816A (en) 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
AU2003261935A1 (en) 2002-09-06 2004-03-29 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
US7129220B2 (en) 2003-08-01 2006-10-31 Janssen Pharmaceutica N.V Substituted indole-O-glucosides
US20070202179A1 (en) * 2004-04-09 2007-08-30 FAULKNER Patrick Low Dose Pharmaceutical Products
JP2009523132A (ja) * 2006-01-10 2009-06-18 スミスクライン ビーチャム コーポレーション ｛２−メチル−４−［４−メチル−２−（４−トリフルオロメチルフェニル）チアゾール−５−イルメチルチオ］フェノキシ｝−酢酸の多形体形態
WO2012168948A2 (en) * 2011-06-06 2012-12-13 Hetero Research Foundation Process for febuxostat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE451346T1 (de) 1998-03-10 2009-12-15 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
US7091225B2 (en) * 2000-12-20 2006-08-15 Smithkline Beecham Corporation Substituted oxazoles and thiazoles as hPPAR alpha agonists
GB0111523D0 (en) * 2001-05-11 2001-07-04 Glaxo Group Ltd Chemical compounds
GB0113233D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JP2004532265A (ja) 2004-10-21
NZ529486A (en) 2005-12-23
AU2002317764B2 (en) 2005-01-06
EP1395572A1 (en) 2004-03-10
DE60208682D1 (de) 2006-04-06
NO20035313D0 (no) 2003-11-28
HUP0400117A3 (en) 2005-09-28
DE60208682T2 (de) 2006-08-24
US20040242657A1 (en) 2004-12-02
HUP0400117A2 (hu) 2005-03-29
GB0113232D0 (en) 2001-07-25
CO5540298A2 (es) 2005-07-29
BR0209892A (pt) 2004-06-08
ATE315556T1 (de) 2006-02-15
ES2256493T3 (es) 2006-07-16
US7244849B2 (en) 2007-07-17
KR20040007631A (ko) 2004-01-24
WO2002096893A1 (en) 2002-12-05
CA2448101A1 (en) 2002-12-05
CZ20033256A3 (en) 2004-04-14
MXPA03010943A (es) 2004-02-27
EP1395572B1 (en) 2006-01-11
PL367114A1 (en) 2005-02-21
CN1551871A (zh) 2004-12-01
NO20035313L (no) 2003-12-09
ZA200308570B (en) 2005-02-03

Similar Documents

Publication Publication Date Title
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
GB0318343D0 (en) No title
MY136685A (en) Thiazole derivatives for treating ppar related disorders
TW200637822A (en) Process for the preparation of a 2-pyridylethylcarboxamide derivative
TW200633981A (en) Process for the preparation of a 2-ethylaminopyridine derivative
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
CY1106743T1 (el) Μεθοδος παρασκευης θειαμεθοξαμης
MXPA05009668A (es) Proceso libre de azida para preparar compuestos de 1,2-diamino.
JO2413B1 (en) Benzoxazine derivatives and their use
MXPA03004426A (es) Proceso quimico y nuevos intermediarios.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
YU61103A (sh) Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
IL158641A0 (en) Process for preparing a thiazole ppar-ligand and polymorphs thereof
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
MY138550A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139159A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
HK1074833A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
WO2004039776A3 (en) A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
MY139348A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY130656A (en) Benzo [g] quinoline derivatives for treating glaucoma and myopia
HU0201262D0 (xx)
SI1200417T1 (en) Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana